- Home
- BHE vs RGC Comparison
BHE vs RGC Comparison
Compare BHE & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHE | RGC |
|---|---|---|
| Founded | 1979 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BHE | RGC |
|---|---|---|
| Price | $74.44 | $5.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $55.00 | N/A |
| AVG Volume (30 Days) | ★ 292.4K | 169.9K |
| Earning Date | 04-29-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $2,659,108,000.00 | N/A |
| Revenue This Year | $7.03 | N/A |
| Revenue Next Year | $6.57 | N/A |
| P/E Ratio | $79.81 | ★ N/A |
| Revenue Growth | ★ 0.11 | N/A |
| 52 Week Low | $35.97 | $4.51 |
| 52 Week High | $100.41 | $69.00 |
Technical Indicators
Market Signals| Indicator | BHE | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 44.22 | 43.91 |
| Support Level | $72.31 | $4.71 |
| Resistance Level | $86.86 | $6.40 |
| Average True Range (ATR) | 2.12 | 0.55 |
| MACD | 0.52 | 0.04 |
| Stochastic Oscillator | 43.00 | 17.00 |
Price Performance
Historical ComparisonAbout BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia, and Europe, of which key revenue is derived from the Americas.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.